Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > Promising results from latest update in DMT trials

View:

Post by XeniaTechie on Apr 13, 2023 1:50pm

Promising results from latest update in DMT trials

Algernon Pharmaceuticals' phase one study of DMT for stroke patients involves escalating doses to understand safety and tolerability. First and second cohort showed promising results with latest results from 2nd cohort as successfully dosed without any issues. The study aims to stimulate brain-derived neurotrophic factor (BDNF) production to aid healing. With continued positive results, AGN will move forward with larger clinical trials further investigating the effectiveness of DMT in treating stroke patients.

https://www.youtube.com/watch?v=2XM7SC5iQaI

187